What is the dosage and treatment plan for Nystatin (antifungal medication) in treating fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nystatin Dosing and Treatment for Fungal Infections

For mild oropharyngeal candidiasis, nystatin suspension 400,000-600,000 units (4-6 mL) four times daily or nystatin pastilles 200,000 units (1-2 pastilles) 4-5 times daily for 7-14 days is recommended as an alternative to topical azoles, though fluconazole is superior for moderate-to-severe disease. 1

Oropharyngeal Candidiasis Dosing

Mild Disease

  • Nystatin suspension (100,000 U/mL): 4-6 mL four times daily for 7-14 days 1
  • Nystatin pastilles (200,000 U each): 1-2 pastilles 4-5 times daily for 7-14 days 1
  • The preparation should be retained in the mouth as long as possible before swallowing 2
  • Continue treatment for at least 48 hours after symptoms disappear and cultures confirm eradication 2

Pediatric Dosing

  • Infants: 2 mL (200,000 units) four times daily using dropper to place half the dose in each side of mouth; avoid feeding for 5-10 minutes 2
  • Premature/low birth weight infants: 1 mL four times daily is effective 2
  • Children: 4-6 mL (400,000-600,000 units) four times daily 2

Important Caveats

  • Nystatin is positioned as an alternative agent, not first-line therapy 1
  • Clotrimazole troches or miconazole buccal tablets are preferred topical options with stronger evidence 1
  • For moderate-to-severe oropharyngeal candidiasis, oral fluconazole 100-200 mg daily for 7-14 days is superior 1

Vulvovaginal Candidiasis

C. glabrata Infection (Azole-Refractory)

  • Nystatin intravaginal suppositories: 100,000 units daily for 14 days 1
  • This is recommended specifically for C. glabrata vulvovaginitis unresponsive to oral azoles 1
  • Topical intravaginal boric acid 600 mg daily for 14 days is the preferred alternative 1

Cutaneous Candidiasis

Skin Infections and Intertrigo

  • Topical nystatin cream is effective for nonhematogenous primary skin infections, particularly intertrigo in skin folds 1
  • Keeping the infected area dry is equally important as antifungal therapy 1
  • For recurrent groin candidiasis with persistent moisture (wheelchair-bound, incontinence), apply topical azole cream twice daily for 14 days, then once daily maintenance therapy 3

Severe Burn Wounds

  • Nystatin powder (6,000 units/g) has been used successfully for angioinvasive fungal infections in severely burned patients 4
  • This is reserved for refractory cases where other topical and systemic agents have failed 4

Prophylaxis in High-Risk Populations

Very-Low-Birthweight Infants

  • Prophylactic oral nystatin: 1 mL (100,000 units/mL) every 8 hours until 1 week after extubation reduces fungal colonization and systemic infection 5
  • This significantly decreases both colonization (12% vs 44%) and systemic infection (6% vs 32%) compared to no prophylaxis 5

Leukemia Patients

  • Nystatin is NOT recommended for prophylaxis in severely immunodepressed patients 6
  • Fluconazole 200 mg daily is significantly more effective than nystatin 6,000 IU daily for preventing fungal infections during chemotherapy 7, 6
  • Nystatin showed no benefit over placebo for fungal colonization in immunocompromised patients 6

Efficacy Considerations

Evidence-Based Dosing Strategies

  • Nystatin pastilles alone or combined with suspension are more effective than suspension alone 8
  • Higher pastille doses (400,000 IU) achieve better mycological cure rates than 200,000 IU 8
  • Extended treatment duration (4 weeks) appears more effective than 2 weeks for pastilles 8
  • Nystatin pastille is superior to placebo for denture stomatitis but not superior to fluconazole for oral candidiasis in HIV/AIDS patients 8

Common Pitfalls

  • Do not use nystatin for esophageal candidiasis: Topical therapy is ineffective; systemic azoles or IV amphotericin B are required 1
  • Avoid nystatin monotherapy in immunocompromised adults: Fluconazole or other systemic azoles are superior 7, 6
  • Poor taste and gastrointestinal adverse effects are the most common side effects limiting compliance 8
  • Nystatin has no role in treating candidemia or invasive candidiasis: Systemic therapy with echinocandins or azoles is mandatory 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Recurrent Groin Candidiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nystatin prophylaxis and treatment in severely immunodepressed patients.

The Cochrane database of systematic reviews, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.